- Home
- RVNC vs OLMA Comparison
RVNC vs OLMA Comparison
Compare RVNC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- OLMA
- Stock Information
- Founded
- RVNC 1999
- OLMA 2006
- Country
- RVNC United States
- OLMA United States
- Employees
- RVNC N/A
- OLMA N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- RVNC Health Care
- OLMA Health Care
- Exchange
- RVNC Nasdaq
- OLMA Nasdaq
- Market Cap
- RVNC 320.5M
- OLMA 465.4M
- IPO Year
- RVNC 2014
- OLMA 2020
- Fundamental
- Price
- RVNC $3.09
- OLMA $6.10
- Analyst Decision
- RVNC Hold
- OLMA Strong Buy
- Analyst Count
- RVNC 9
- OLMA 5
- Target Price
- RVNC $8.45
- OLMA $26.25
- AVG Volume (30 Days)
- RVNC 3.6M
- OLMA 1.1M
- Earning Date
- RVNC 11-07-2024
- OLMA 11-12-2024
- Dividend Yield
- RVNC N/A
- OLMA N/A
- EPS Growth
- RVNC N/A
- OLMA N/A
- EPS
- RVNC N/A
- OLMA N/A
- Revenue
- RVNC $256,945,000.00
- OLMA N/A
- Revenue This Year
- RVNC $11.28
- OLMA N/A
- Revenue Next Year
- RVNC $27.21
- OLMA N/A
- P/E Ratio
- RVNC N/A
- OLMA N/A
- Revenue Growth
- RVNC 25.82
- OLMA N/A
- 52 Week Low
- RVNC $2.30
- OLMA $5.56
- 52 Week High
- RVNC $9.75
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- OLMA 27.05
- Support Level
- RVNC $3.06
- OLMA $5.56
- Resistance Level
- RVNC $3.09
- OLMA $6.87
- Average True Range (ATR)
- RVNC 0.11
- OLMA 0.81
- MACD
- RVNC 0.02
- OLMA -0.28
- Stochastic Oscillator
- RVNC 6.90
- OLMA 10.12
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.